Form 4: Health Catalyst Director Julie Larson-Green Acquires 1,616 Shares Through RSU Vesting

Director Julie Larson-Green acquired 1,616 shares of Health Catalyst stock through the vesting of restricted stock units on December 1, 2024.

Summary

• Julie Larson-Green, a director at Health Catalyst, Inc., acquired 1,616 shares of common stock.
• The acquisition occurred through the vesting of restricted stock units (RSUs).
• These RSUs were granted under the company's 2019 Stock Option and Incentive Plan.
• Each RSU represents the right to receive one share of Health Catalyst common stock.
• The RSUs vested on December 1, 2024, as per the terms of the plan and the Non-Employee Director Compensation Policy.
• The price per share at the time of vesting was $0.00, as it was a grant.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to slightly positive as it aligns director interests with shareholders.

Positives

• The vesting of RSUs indicates alignment of director interests with the company's performance.
• The acquisition of shares increases the director's stake in the company.

Industry Context

This is a routine transaction for a director of a public company, and is a common way for directors to be compensated and incentivized.

Comparison to Industry Standards

• The vesting of restricted stock units is a standard practice for compensating directors in publicly traded companies.
• Many companies use similar stock option and incentive plans to align the interests of directors with shareholders.
• The number of shares granted is typical for a director's compensation package.

Stakeholder Impact

• The transaction increases the director's stake in the company, aligning her interests with shareholders.
• The vesting of RSUs is part of the company's compensation strategy.

Key Dates

Keywords

Health Catalyst, Director, Julie Larson-Green, RSU, Restricted Stock Units, Stock Acquisition, Share Vesting, Insider Trading, SEC Form 4